Scientists have discovered that ‘rogue’ antibodies found circulating in the blood of COVID-19 patients have the potential to cause endothelial cells to lose their resistance to clotting. These antiphospholipid autoantibodies can trigger blood clots in the arteries and veins of patients with autoimmune disorders, including lupus and antiphospholipid syndrome. The findings provide an even stronger connection between autoantibody formation and clotting in COVID-19.
Click here for original story, Rogue antibodies make cells ‘sticky’ to trigger blood clots in COVID-19 patients
Source: ScienceDaily